STUDY OF THE INTERACTIONS BETWEEN PROTEIN KINASE AND QUINAZOLINE DERIVATIVES USING MOLECULAR DOCKING
In this study, the interaction of quinazoline derivatives with protein kinase (PDB code: 4AQC) was studied using molecular docking. The results showed that these derivatives bound with high affinity to the active sites of the selected protein, which helps to explain their biological activity. The docking results may be useful in the development of new drug substances.
1. Khan I., Zaib S., Batool S., Abbas N., Ashraf Z., Iqbal J., Saeed A., Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: an update on the development of synthetic methods and pharmacological diversification, Bioorg. Med. Chem. 24 (2016) 2361-2381.
2. Ismail R.S.M., Ismail N.S.M., Abuserii S., Abou El Ella D.A., Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents, Future J. Pharm. Sci. 2 (2016) 9-19.
3. Alagarsamy V., Chitra K., Saravanan G., Solomon V.R., Sulthana M.T., Narendhar B., An overview of quinazolines: pharmacological significance and recent developments, Eur. J. Med. Chem. 151 (2018) 628-685.
4. Singh K., Sharma P.P., Kumar A., Chaudhary A., Roy R.K., 4-Aminoquinazoline analogs: a novel class of anticancer agents, Mini Rev. Med. Chem. 13 (2013) 1177-1194.
5. Lipunova G.N., Nosova E.V., Charushin V.N., Chupakhin O.N., Synthesis and antitumour activity of 4-aminoquinazoline derivatives, Russ. Chem. Rev. 85 (2016) 759-793.
6. Wang, D., Gao, F, Quinazoline derivatives: synthesis and bioactivities. Chem. Cent. J. 7, 95, (2013).
7. Asif, M., Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivative. Int. J. Med. Chem. (2014) 395637.
8. Qiao, H., Zhao, D., Shi, H., et al. Novel quinazoline derivatives exhibit antitumor activity by inhibiting JAK2/STAT3. Oncol. Rep. 34, (2015) 1875–1882.
9. Yang, S.H., Khadka, D.B., Cho, S.H., et al., Virtual screening and synthesis of quinazolines as novel JAK2 inhibitors. Bioorg. Med. Chem. 19, (2011) 968–977.
10. Jyothi Buggana, S.; Paturi, M.C.; Perka, H.; Gade, D.R.; Vvs, R.P. Novel 2,4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies. Comput. Biol. Chem. 79 (2019) 110– 118.
11. Das, D.; Hong, J. Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry. Eur. J. Med. Chem. 170 (2019) 55–72. 12. Aly, A.A., Synthesis and antimicrobial activity of some annelated quinazoline derivatives. J. Chin. Chem. Soc. 54 (437) (2007) 46.
13. Hans-Dieter Höltje, Rainer Willett, Pierre J. van der Greef Molecular Docking: Methods and Applications, Wiley-VCH, 2004, - 290 pages.
14. Kuntz, I.D., et al., Molecular docking: a powerful approach for structure-based drug design, Nature, 1982.
15. Kitchen, D.B., et al., Protein-ligand docking and virtual screening with docking, Nature Reviews Drug Discovery, 2004.
16. Trott, O., & Olson, A.J., Recent advances in molecular docking: a review, Journal of Computational Chemistry, 2010.
17. Jacobson, M.P., et al., Docking of proteins and ligands: Applications to drug design, Current Opinion in Structural Biology, 2004.
18. Gilson, M.K., & Zhou, H.-X., Challenges and advances in the use of molecular docking to predict protein-ligand binding, Annual Review of Biophysics, 2007.
19. Gasteiger, J., & Engel, T., Molecular docking and virtual screening: A review, Bioinformatics, 2003.
Copyright (c) 2025 ACTA NUUz
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
.jpg)
1.png)
